Monday, Aug 24 | --:--
Back to home

OpenAI Doubles Bio Bug Bounty to $50K and Makes It Ongoing for GPT-5.6

On July 9, 2026—the same day GPT-5.6 went public—OpenAI evolved its GPT-5.5 Bio Bug Bounty into an ongoing private OpenAI Bio Bounty Program focused on universal jailbreaks against a predefined biosafety challenge, raised the top award from $25,000 to $50,000, and put GPT-5.6 in scope alongside GPT-5.5.

Tech Insights Reporter 4 min read San Francisco, CA
Cover illustration for OpenAI Doubles Bio Bug Bounty to $50K and Makes It Ongoing for GPT-5.6

TLDR

OpenAI on July 9, 2026 announced that its GPT‑5.5 Bio Bug Bounty is becoming an ongoing private program—the OpenAI Bio Bounty Program—aimed at universal jailbreaks that defeat a fixed biosafety challenge on frontier models, starting with GPT‑5.6 and continuing forward. The top reward rises from $25,000 to $50,000 for a qualifying universal jailbreak on GPT‑5.6 and GPT‑5.5; partial awards remain discretionary. GPT‑5.5 stays in scope through the prior testing window (through July 27, 2026 per contemporaneous program notes).

What changed

From OpenAI’s primary “OpenAI Bio Bug Bounty” safety post (July 9) and TechRepublic / program page context:

Item Detail
From Time-boxed GPT‑5.5 bio red-team bounty (applications earlier in 2026)
To Ongoing private Bio Bounty Program
Target Universal jailbreaks vs predefined biosafety challenge
Models GPT‑5.6 in scope from launch; GPT‑5.5 retained
Top award $50,000 (was $25,000)
Access Invite / application-based private program for vetted red-teamers

OpenAI frames the program as part of strengthening safeguards for advanced biology capabilities as frontier models ship—explicitly tying the escalation to the GPT‑5.6 public era, not a standalone marketing drop.

Why this story matters

Model launch days usually bury safety ops. Pairing a public GPT‑5.6 unlock with a doubled, permanent bio jailbreak bounty is OpenAI advertising external adversarial testing as continuous infrastructure—especially for a risk domain (biorisk) that governments and enterprises treat as non-negotiable. It also sets a competitive benchmark: other labs either match external bio red-team incentives or explain why not.

Sources

Prior Coverage

Earlier Times of AI reporting on this thread.

Scroll to continue reading